Evidence map›Paper›PMID 23286544›Full record

ArticleBMC musculoskeletal disorders2013

Time course of 25(OH)D3 vitamin D3 as well as PTH (parathyroid hormone) during fracture healing of patients with normal and low bone mineral density (BMD).

Christoph Wölfl, Christoph Wöfl, Sarah Englert, Arash A Moghaddam, Gerald Zimmermann, Heinrich Schmidt-Gayk, Gerhard Schmidt-Gayk, Bernd Höner, Aidan Hogan, Marcus Lehnhardt and 2 more

Erratum issuedOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC musculoskeletal disorders, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Bone turnover markers as determinants of bone density and fracture in men with distal forearm fractures: the pathogenesis examined in the Mr F study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

  • Erratum issued
    Wöfl, Christoph [corrected to Wölfl, Christoph]; Schmidt-Gayk, Gerhard [corrected to Schmidt-Gayk, Heinrich]
5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Christoph Wölfl
Christoph WöflDepartment of Trauma- and Orthopaedic Surgery, BG Trauma Centre Ludwigshafen, Ludwigshafen, Germany. cwoelfl@bgu-ludwigshafen.de
Sarah Englert
Arash A Moghaddam
Gerald Zimmermann
Heinrich Schmidt-Gayk
Gerhard Schmidt-Gayk
Bernd Höner
Aidan Hogan
Marcus Lehnhardt
Paul A Grützner
Leila Kolios
Klinikum Ludwigshafen · DEBerufsgenossenschaftliche Unfallklinik Ludwigshafen · DEAkademie für Gesundheitsberufe · DELudwigshafen University of Business and Society · DEUniversity of Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUntil now the exact biochemical processes during healing of metaphyseal fractures of healthy and osteoporotic bone remain unclear. Especially the physiological time courses of 25(OH)D(3) (Vitamin D) as well as PTH (Parathyroid Hormone) the most important modulators of calcium and bone homeostasis are not yet examined sufficiently. The purpose of this study was to focus on the time course of these parameters during fracture healing.

methodsIn the presented study, we analyse the time course of 25(OH)D3 and PTH during fracture healing of low BMD level fractures versus normal BMD level fractures in a matched pair analysis. Between March 2007 and February 2009 30 patients older than 50 years of age who had suffered a metaphyseal fracture of the proximal humerus, the distal radius or the proximal femur were included in our study. Osteoporosis was verified by DEXA measuring. The time courses of 25(OH)D(3) and PTH were examined over an eight week period. Friedmann test, the Wilcoxon signed rank test and the Mann-Withney U test were used as post-hoc tests. A p-value ≤ 0.05 was considered significant.

resultsSerum levels of 25(OH)D(3) showed no differences in both groups. In the first phase of fracture healing PTH levels in the low BMD level group remained below those of the normal BMD group in absolute figures. Over all no significant differences between low BMD level bone and normal BMD level bone could be detected in our study.

conclusionsThe time course of 25(OH)D(3) and PTH during fracture healing of patients with normal and low bone mineral density were examined for the first time in humans in this setting and allowing molecular biological insights into fracture healing in metaphyseal bones on a molecural level. There were no significant differences between patients with normal and low BMD levels. Hence further studies will be necessary to obtain more detailed insight into fracture healing in order to provide reliable decision criteria for therapy and the monitoring of fracture healing.

Indexed as

Bone DensityFracture HealingAbsorptiometry, PhotonBiomarkersCalcifediolFemaleFemoral FracturesHumansMaleMatched-Pair AnalysisMiddle AgedOsteoporosisParathyroid HormoneRadius FracturesShoulder FracturesTime FactorsBiomarkersCalcifediolParathyroid HormonePTH protein, human

Identifiers

PMID23286544
PMCPMC3544577
OpenAlexW2114943835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.